Create a narrative

EDAP TMS Community

NasdaqGM:EDAP Community

1 Narratives written by author
0 Comments on narratives written by author
1 Fair Values set on narratives written by author

Create a narrative

AN

AnalystConsensusTarget

Consensus Narrative from 3 Analysts

CE Mark And Global Expansion Will Elevate HIFU Adoption

Key Takeaways New approvals and strategic collaborations enhance EDAP TMS's market opportunities, potentially driving future revenue growth and improving margins. Expanded market presence through international and U.S. expansions may lead to increased utilization and revenue from Focal One.

US$8.50

FV

74.7% undervalued

8.20%

Revenue growth p.a.

0

0

1

Updated